Journal article
SOCS3 regulates graft-versus-host disease
GR Hill, RD Kuns, NC Raffelt, ALJ Don, SD Olver, KA Markey, YA Wilson, J Tocker, WS Alexander, AD Clouston, AW Roberts, KPA MacDonald
Blood | Published : 2010
Abstract
Suppressor of cytokine signaling-3 (SOCS3) is the main intracellular regulator of signaling by granulocyte colony-stimulating factor, an immune-modulatory cytokine used to mobilize stem cells for transplantation. We have therefore studied the contribution of SOCS3 to the spectrum of graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (SCT). Grafts from SOCS3-/Δvav donor mice in which SOCS3 deficiency is restricted to the hematopoietic compartment had an augmented capacity to induce acute GVHD. With the use of SOCS3+/ΔLysM and SOCS3-/Δlck donors in which SOCS3 deficiency was restricted to the myeloid or T-cell lineage, respectively, we confirmed SOCS3 deficiency promot..
View full abstractGrants
Awarded by National Cancer Institute
Funding Acknowledgements
This work was supported in part by grants from the Queensland Cancer Fund, the National Institutes of Health (CA022556), and National Health and Medical Research Council (programs 461291 and 351439). K. P. A. M. is a National Health and Medical Research Council R. D. Wright Fellow. W. S. A., A. W. R., and G. R. H. hold fellowships from the National Health and Medical Research Council (Australia).